ArticleCancer medicine2026

Increased Lymphocyte Proportions as a Candidate Biomarker for Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitors and Chemotherapy.

Nanami Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.